Influence of lynch syndrome on the incidence of side effects to antineoplastic treatment of patients with colorectal cancer.
1/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
161 patients with suspected Lynch Syndrome, all undergoing chemotherapy.
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
This finding may be related to biological and physiological factors, including greater cellular variability, the need for more intensive therapeutic regimens, and the influence of individual genetic variability. These results highlight the importance of personalized approaches in managing the side effects of cancer treatment.
To analyze the influence of Lynch Syndrome on the incidence of adverse reactions to antineoplastic treatment in patients with colorectal cancer.
APA
Alencar AVS, Barreto GAV, et al. (2025). Influence of lynch syndrome on the incidence of side effects to antineoplastic treatment of patients with colorectal cancer.. Cancer genetics, 298-299, 169-179. https://doi.org/10.1016/j.cancergen.2025.10.001
MLA
Alencar AVS, et al.. "Influence of lynch syndrome on the incidence of side effects to antineoplastic treatment of patients with colorectal cancer.." Cancer genetics, vol. 298-299, 2025, pp. 169-179.
PMID
41082795 ↗
Abstract 한글 요약
To analyze the influence of Lynch Syndrome on the incidence of adverse reactions to antineoplastic treatment in patients with colorectal cancer. Observational and retrospective study based on analyzing electronic medical records of patients treated at Hospital Haroldo Juaçaba/Ceará Cancer Institute (HHJ/ICC). Patients with NCCN clinical criteria for Lynch Syndrome and a diagnosis of colorectal cancer were included, comparing the profile of adverse reactions to chemotherapy between those with and without pathogenic mutations associated with the syndrome. The sample consisted of 161 patients with suspected Lynch Syndrome, all undergoing chemotherapy. A higher frequency of adverse reactions was observed among patients without a pathogenic mutation for Lynch Syndrome. Approximately two-thirds of the sample reported adverse reactions, with nausea being the most common adverse event, followed by neurotoxicity and diarrhea. Patients with colorectal cancer without a pathogenic mutation for Lynch syndrome had a higher incidence of adverse reactions to chemotherapy. This finding may be related to biological and physiological factors, including greater cellular variability, the need for more intensive therapeutic regimens, and the influence of individual genetic variability. These results highlight the importance of personalized approaches in managing the side effects of cancer treatment.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.